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Correlations between biomarkers  
of oxidative stress, glycemic control  
and insulin resistance in women  
with type 2 diabetes
ABSTRACT 
Background. The main characteristic of type 2 diabetes 
mellitus (T2DM) is hyperglycemia due to insulin resist-
ance. Enhanced oxidative stress owing to increased 
oxygen free radicals and/or reduced antioxidant de-
fense has very important roles in T2DM development 
and also most of its complications. The aim of the 
current study was to evaluate correlations between 
biomarkers of oxidative stress, glycemic control and 
insulin resistance in women with T2DM.
Materials and methods. Seventy nine women with T2DM 
were included in the current study and fasting blood 
samples were collected. Hemoglobin A1c (HbA1c); glucose; 
oxidative stress biomarkers including malodialdehyde, 
8-isoprostane, catalase and total antioxidant capacity 
(TAC) were measured. The adiponectin/leptin (A/L) ratio 
and the homeostasis model assessment of beta-cell 
function (HOMA-B) were calculated. The results were con-
sidered significant when the p-value was less than 0.05.
Results. Serum levels of TAC showed a significant 
positive correlation with the A/L ratio (r = 0.261, 
p = 0.02). A significant negative correlation was ob-
served between values of HbA1c and TAC (r = –0.300, 
p = 0.007). However, HbA1c correlated positively with 
8-isoprostane (r = 0.236, p = 0.036). Values of HOMA-B 
correlated negatively with values of HbA1c (r = –0.327, 
p = 0.003). Serum levels of 8-isoprostane were signifi-
cantly higher in obese (BMI > 30 kg/m2) women than 
in non-obese (BMI < 30 kg/m2) women (p = 0.032). 
Values of catalase (p = 0.022) and HOMA-B (p = 0.009) 
were significantly lower in women with HbA1c ≥ 7.6% 
compared with women with HbA1c < 7.6%.
Conclusions. In summary, chronic hyperglycemia re-
sults in oxidative stress. This situation might lead to 
less beta cells function. In addition, low levels of the A/L 
ratio were associated with increased oxidative stress. 
(Clin Diabetol 2019; 8, 6: 277–283)
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Introduction
The main characteristic of type 2 diabetes mellitus 
(T2DM) is hyperglycemia due to insulin resistance. In-
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sulin resistance also can lead to metabolic impairment 
of other biomolecules such as lipids and proteins [1]. 
Enhanced oxidative stress owing to increased oxygen 
free radicals and/or reduced antioxidant defense has 
very important roles in T2DM development and also 
most of its complications [2]. Studies have shown that 
oxidative stress has a central role in insulin resistance 
development [3]. 
Increased circulating levels of glucose can cause 
oxidative stress via overproduction of reactive oxygen 
species [4]. On the other hand, beta cells function is 
impaired during chronic hyperglycemia because of 
increased oxidative stress which damages the cells [5]. 
Since antioxidant enzymes activities are low in 
beta cells, they are very sensitive to destructive effects 
of oxidative stress. On the other hand, lipotoxicity in-
duced in beta cells by means of oxidative stress might 
be a central mechanism of destructive effects of reac-
tive oxygen species in these insulin-secreting cells [6]. 
Current literature shows that oxidant/antioxidant bal-
ance is disrupted in people with obesity that leads to 
increased oxygen free radicals production which means 
an oxidative stress condition [4].
The current study was designed to evaluate correla-
tions between biomarkers of oxidative stress, glycemic 
control and insulin resistance in women with T2DM.
Materials and methods 
The current study was performed after approving 
by the Ethics Committee of the University. Eighty Persian 
women with T2DM were selected using convenience 
sampling method according to World Health Organi-
zation (WHO) [7] criteria after signing an informed 
consent form. One of the patients was excluded from 
the study. Therefore, the final sample size became 79 
women with T2DM. Among the patients 54% were in 
premenopausal status and 46% were in postmeno-
pausal status (p = 0.574). Age range of the patients 
was 40–65 years.
No more than 2 years of T2DM duration and not 
taking antioxidants supplements during the last three 
months were inclusion criteria of the current study. Pa-
tients under treatment with insulin and other hormone, 
anticoagulants, diuretics and b-blockers were excluded 
from the study. Other exclusion criteria were alcoho-
lism, smoking, pregnancy, lactation and any chronic 
renal, hepatic, thyroid, haematic and gastrointestinal 
disorders.
Systolic and diastolic blood pressures, waist cir-
cumference (WC) and weight were measured and body 
mass index (BMI) was calculated and reported as kg/m2.
Subjects were divided into two groups including obese 
(BMI > 30 kg/m2) and non-obese (BMI < 30 kg/m2) [8]. 
Subjects were also divided into two groups accord-
ing to hemoglobin A1c (HbA1c) values (HbA1c < 7.6% 
and HbA1c ≥ 7.6%) [9]. As glucose-lowering drugs, 
all patients were under treatment with metformin or 
a combination of metformin and glibenclamide.  
After 12 hours of overnight fasting, blood samples 
were collected. Hemoglobin A1c was assessed using 
column chromatography method (Biosistem, Spain). Se-
rum values of glucose and Gamma-glutamyltransferase 
enzyme (GGT) were evaluated using commercially avail-
able colorimetric methods (Parsazmun, Iran). Other 
assays were included activity of catalase using spec-
trophotometric method [10], the ferric reducing ability 
of plasma (FRAP) assay for evaluating total antioxidant 
capacity (TAC) [11] and the thiobarbituric acid (TBA) as-
say for determining malodialdehyde (MDA) [12]. Other 
assays included insulin (Monobind Inc., USA), leptin 
and total adiponectin (BioVendor Laboratory Medicine, 
Inc. Czech Republic) and free 8-isoprostane (Cayman 
Chemical, Ann Arbor, MI, USA) using enzyme-linked 
immunosorbent assay (ELISA) on a microplate reader 
(STAT FAX 4200, USA).
The homeostasis model assessment of insulin 
resistance (HOMA-IR) [13], the quantitative insulin 
sensitivity check index (QUICKI) [14], the homeostasis 
model assessment of b-cell function (HOMA-B) [5], the 
leptin/adiponectin ratio (L/A) [13] and the adiponectin/ 
/leptin ratio (A/L) [15] were calculated.
Statistical analysis were done using Kolmogo-
rov–Smirnov test for exploring normal and skewed 
distributed variables, independent-samples t-test and 
Mann-Whitney U-test for analyzing differences in 
demographic and biochemical data in Tables 1 and 2 
and Pearson’s and Spearman’s correlation analyses for 
exploring correlations between biochemical variables in 
SPSS 19 software (SPSS Inc, Chicago, IL). Chi-square test 
was used for qualitative analysis. The mean ± SEM was 
used for expressing the variables and were considered 
statistically significant at a p-value less than 0.05.
Results
Demographic and biochemical characteristics of 
women with T2DM are presented in Table 1. Correla-
tions were assessed in whole of the subjects. Serum 
levels of malodialdehyde correlated negatively with 
levels of adiponectin (r = –0.30, p =  0.007) (Figure 1). 
A negative correlation was observed between se-
rum levels of 8-isoprostane and activities of catalase 
(r = –0.24, p = 0.032). A significant positive correlation 
was observed between serum activities of GGT and val-
ues of waist circumference (r = 0.23, p = 0.041). Serum 
levels of TAC showed a significant positive correlation 
with the A/L ratio (r = 0.261, p = 0.02) (Figure 2). 
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However, TAC correlated negatively with the L/A ratio 
(r = –0.262, p = 0.02). A significant negative correla-
tion was observed between values of HbA1c and TAC 
(r = –0.300, p = 0.007). However, HbA1c correlated 
positively with 8-isoprostane (r = 0.236, p = 0.036) 
(Figure 3). Values of HOMA-B correlated negatively 
with values of HbA1c (r = –0.327, p = 0.003) (Figure 4). 
A significant positive correlation was observed between 
values of FBS and HbA1c (r = 0.32, p = 0.004). Serum 
activities of GGT showed a slightly positive correlation 
with levels of malodialdehyde (r = 0.219, p = 0.051).
Comparison of demographic and biochemical char-
acteristics of obese and non-obese women with T2DM 
was presented in Table 2. Obese women had higher 
values of waist circumference (p < 0.001), weight 
(p < 0.001) and BMI (p < 0.001) than non-obese wom-
en. Serum levels of 8-isoprostane were significantly 
higher in obese women than in non-obese women 
(p = 0.032). Marginally decreases were observed in 
values of HOMA-B (p = 0.091) and TAC (p = 0.087) 
in obese women compared with non-obese women. 
HOMA-IR was nonsignificantly higher in obese women 
compared with non-obese women.
Table 3 shows comparison of demographic and 
biochemical characteristics of women with T2DM ac-
cording to HbA1c values. Women with HbA1c ≥ 7.6% had 
higher values of FPG (p = 0.006), HbA1c (p < 0.001), SBP 
(p = 0.006) and HOMA-IR (p = 0.027) than women with 
HbA1c < 7.6%. However, values of catalase (p = 0.022) 
Table 1. Demographic and biochemical characteristics of 
women with type 2 diabetes mellitus (T2DM)
Variables T2DM (n = 79)
Age (years) 53.09 ± 0.73
Duration of diabetes (year) 4.94 ± 0.30
Waist [cm] 103.68 ± 0.99
Weight [kg] 72.98 ± 1.05
BMI [kg/m2] 28.53 ± 0.38
SBP [mm Hg] 12.59 ± 0.17
DBP [mm Hg] 8.03 ± 0.08
FBG [mg/dl] 139.86 ± 5.41
HbA1c (%) 8.68 ± 0.24
Insulin [mIU/l] 13.99 ± 0.50
Adiponectin [µg/ml] 6.71 ± 0.33
Leptin [µg/ml] 21.92 ± 1.35
A/L ratio 0.43 ± 0.04
L/A ratio 3.94 ± 0.38
MDA [nmol/ml] 11.37 ± 0.39
8-isoprostane [pg/ml] 401.19 ± 9.96
Catalase [KU] 2.05 ± 0.11
GGT [U/L] 32.94 ± 2.50
TAC [mmol/L] 0.30 ± 0.01
HOMA-IR 4.82 ± 0.25
HOMA-B 99.84 ± 12.50
QUICKI 0.31 ± 0.002
Results are presented as mean ± SEM. BMI — body mass index; SBP — 
systolic blood pressure; DBP — diastolic blood pressure; FBG — fasting 
blood glucose; HbA1c — hemoglobin A1c; A/L — the adiponectin/leptin 
ratio; L/A — the leptin/adiponectin ratio; MDA — malodialdehyde; GGT — 
gamma-glutamyl transferase; TAC — total antioxidant capacity; HOMA-IR 
— homeostasis model assessment of insulin resistance; HOMA-B — ho-
meostasis model assessment of beta-cell function; QUICKI — quantitative 
insulin sensitivity check index
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Figure 1. Correlation between serum levels of malodialdehyde 
and levels of adiponectin in women with type 2 diabetes mel-
litus (r = –0.30, p = 0.007)
Figure 2. Correlation between serum values of total antioxi-
dant capacity and the adiponectin/leptin ratio in women with 
type 2 diabetes mellitus (r = 0.261, p = 0.02)
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Table 2. Comparison of demographic and biochemical characteristics of obese (BMI > 30 kg/m2) and non-obese (BMI 
< 30 kg/m2) women with type 2 diabetes mellitus
Variables Non-obese (n = 50) Obese (n = 29) p
Age (years) 52.80 ± 0.93 53.59 ± 1.20 0.609
Duration of diabetes (year) 5.06 ± 0.36 4.72 ± 0.54 0.598
Waist [cm[ 100.84 ± 1.09 108.59 ± 1.57 < 0.001
Weight [kg] 68.02 ± 1.06 81.53 ± 0.89 < 0.001
BMI [kg/m2] 26.31 ± 0.28 32.35 ± 0.25 < 0.001
SBP [mm Hg] 12.54 ± 0.22 12.67 ± 0.27 0.881
DBP [mm Hg] 7.93 ± 0.10 8.21 ± 0.13 0.188
FBG [mg/dl] 134.04 ± 6.43 149.90 ± 9.56 0.154
HbA1c (%) 8.57 ± 0.31 8.86 ± 0.37 0.319
Insulin [mIU/l] 14.16 ± 0.62 13.69 ± 0.87 0.652
Adiponectin [µg/ml] 6.60 ± 0.41 6.90 ± 0.54 0.906
Leptin [µg/ml] 22.16 ± 1.69 21.51 ± 2.29 0.818
A/L ratio 0.44 ± 0.06 0.42 ± 0.05 0.428
L/A ratio 4.27 ± 0.55 3.39 ± 0.41 0.428
MDA [nmol/ml] 11.20 ± 0.51 11.65 ± 0.60 0.585
8-isoprostane [pg/ml] 385.03 ± 13.21 429.05 ± 13.53 0.032
Catalase [KU] 2.02 ± 0.14 2.10 ± 0.18 0.744
GGT [U/L] 32.51 ± 3.30 33.67 ± 3.80 0.473
TAC [mmol/L] 0.31 ± 0.01 0.29 ± 0.01 0.087
HOMA-IR 4.63 ± 0.27 5.16 ± 0.51 0.316
HOMA-B 107.69 ± 15.98 86.31 ± 20.13 0.091
QUICKI 0.31 ± 0.002 0.31 ± 0.003 0.677
Results are presented as mean ± SEM. Abbreviations are given in Table 1
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Figure 3. Correlation between values of HbA1c and 8-iso-
prostane in women with type 2 diabetes mellitus (r = 0.236, 
p = 0.036)
Figure 4. Correlation between values of HbA1c and the ho-
meostasis model assessment of beta-cell function (HOMA-B) in 
women with type 2 diabetes mellitus (r = –0.327, p = 0.003)
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and HOMA-B (p = 0.009) (Figure 5) were significantly 
lower in women with HbA1c ≥ 7.6% compared with 
women with HbA1c < 7.6%.
Discussion 
In the current study some important correlations 
were observed including negative correlation between 
values of HbA1c and TAC, negative correlation between 
values of HOMA-B and HbA1c, positive correlation be-
tween values of HbA1c and 8-isoprostane and positive 
correlation between values of the A/L ratio and TAC.
A study conducted by Picu et al. [4] has shown 
a positive correlation between total oxidant status 
(TOS) and HbA1c in patients with T2DM. Therefore, it 
has been hypothesized that prolonged hyperglycemia 
results in overproduction of reactive oxygen species 
which leads to oxidative stress. In the current study, 
Table 3. Comparison of demographic and biochemical characteristics of women with type 2 diabetes mellitus according 
to HbA1c values
Variables HbA1c < 7.6% (n = 27) HbA1c ≥ 7.6% (n = 52) p
Age (years) 53.44 ± 1.02 52.90 ± 0.99 0.730
Duration of diabetes (year) 5.15 ± 0.43 4.83 ± 0.41 0.620
Waist [cm] 102.56 ± 1.94 104.27 ± 1.11 0.413
Weight [kg] 71.41 ± 1.76 73.80 ± 1.30 0.282
BMI [kg/m2] 27.89 ± 0.58 28.86 ± 0.50 0.233
SBP [mm Hg] 11.92 ± 0.24 12.93 ± 0.21 0.006
DBP [mm Hg] 7.91 ± 0.14 8.10 ± 0.10 0.605
FBG [mg/dl] 120.48 ± 6.16 149.92 ± 7.22 0.006
HbA1c (%) 6.74 ± 0.14 9.68 ± 0.26 < 0.001
Insulin [mIU/l] 14.12 ± 0.76 13.92 ± 0.66 0.852
Adiponectin [µg/ml] 6.59 ± 0.59 6.77 ± 0.39 0.619
Leptin [µg/ml] 23.23 ± 2.43 21.24 ± 1.63 0.487
A/L ratio 0.38 ± 0.05 0.46 ± 0.05 0.451
L/A ratio 4.09 ± 0.59 3.87 ± 0.49 0.451
MDA [nmol/ml] 11.94 ± 0.71 11.07 ± 0.46 0.290
8-isoprostane [pg/ml] 383.81 ± 18.31 410.21 ± 11.71 0.211
Catalase [KU] 2.40 ± 0.23 1.86 ± 0.12 0.022
GGT [U/L] 35.28 ± 5.69 31.72 ± 2.42 0.687
TAC [mmol/L] 0.32 ± 0.01 0.30 ± 0.01 0.120
HOMA-IR 4.15 ± 0.29 5.17 ± 0.34 0.027
HOMA-B 130.24 ± 23.86 84.06 ± 14.08 0.009
QUICKI 0.31 ± 0.003 0.31 ± 0.003 0.137
Results are presented as mean ± SEM. Abbreviations are given in Table 1
Figure 5. Comparison of the homeostasis model assessment 
of b-cell function (HOMA-B) of women with type 2 diabetes 
mellitus according to HbA1c values (p = 0.009)
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a significant negative correlation was observed be-
tween values of HbA1c and TAC. On the other hand, 
current study showed a significant positive correlation 
between values of HbA1c and 8-isoprostane. These 
results could support the hypothesis.
Hou et al. [5] and Al-Hakeim et al. [9] divided 
patients with T2DM according to HbA1c values. They 
observed that patients with higher values of HbA1c have 
lower values of HOMA-B. Therefore, beta cells function 
is affected by glycemic control. A negative correlation 
has shown between values of HOMA-B and HbA1c in 
males with T2DM [16]. In the current study, Values of 
HOMA-B correlated negatively with values of HbA1c in 
the whole patients. In addition, values of catalase and 
HOMA-B were significantly lower in women with HbA1c 
≥ 7.6% compared with women with HbA1c < 7.6%. In-
creased circulating levels of glucose can cause oxidative 
stress via overproduction of reactive oxygen species [4]. 
On the other hand, beta cells function is impaired 
during chronic hyperglycemia because of increased 
oxidative stress which damages the cells [5]. Since an-
tioxidant enzymes activities are low in beta cells, they 
are very sensitive to destructive effects of oxidative 
stress. On the other hand, lipotoxicity induced in beta 
cells by means of oxidative stress might be a central 
mechanism of destructive effects of reactive oxygen 
species in these insulin-secreting cells [6].
Gamma-glutamyltransferase (GGT) is an enzyme 
which is well known as a biomarker of fatty liver and 
alcohol consumption. However, it has been shown 
that GGT shows a direct relationship with incidence 
of diabetes independent of popular risk factors such 
as alcohol consumption. Current literature shows that 
GGT can also be used as a biomarker of oxidative stress 
condition in which its activity increases. GGT activity in 
serum shows a negative correlation with serum levels of 
antioxidants [17, 18]. In the current study, serum activi-
ties of GGT showed a slightly positive correlation with 
levels of malodialdehyde. On the other hand, plasma 
GGT activity is also related to obesity with the risk for 
T2DM [18]. In the current study, a significant positive 
correlation was observed between serum activities of 
GGT and values of waist circumference.
Leptin and adiponectin are adipokines that are 
secreted by white adipose tissue. The principal known 
role of leptin is energy homeostasis regulation. On the 
other hand, pro-inflammatory property of leptin has 
been demonstrated that causes proliferation of mono-
cytes. This property of leptin can cause an increase in 
activity of enzyme nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase which leads to an increase 
in oxygen free radicals production. In other words, 
leptin can induce oxidative stress [4]. On the other 
hand, adiponectin has been suggested as the strongest 
anti-inflammatory cytokine and can promote insulin 
sensitization effect. Moreover, some antioxidant effects 
of adiponectin has been reported that can prevent 
mitochondrial depolarization and dysfunction [19, 20]. 
It has been reported that in individuals with metabolic 
syndrome levels of total adiponectin correlates nega-
tively with values of malodialdehyde. Therefore, it has 
been concluded that lower values of the A/L ratio can 
cause increased oxygen free radicals which leads to 
oxidative stress in patients with metabolic syndrome 
[21]. In the current study, serum levels of adiponectin 
correlated negatively with levels of malodialdehyde. 
On the other hand, serum levels of TAC showed 
a significant positive correlation with the A/L ratio and 
a significant negative correlation with the L/A ratio. 
Therefore, low levels of the A/L ratio or high levels of 
the L/A ratio were associated with increased oxidative 
stress in subjects of the current study. 
Study of Picu et al. [4] has shown a positive correla-
tion between total oxidant status and the percentage 
of total body fat in patients with T2DM. Therefore, it 
has been proposed that in obesity oxidant/antioxidant 
balance is disrupted that leads to increased oxygen free 
radicals production which means an oxidative stress 
condition. In the current study, women with BMI > 30 
kg/m2 had higher values of 8-isoprostane and margin-
ally decreased TAC values than women with BMI < 30 
kg/m2 that might indicate an oxidative stress condition. 
The current study had some limitations. The most 
important of them were small sample size and not using 
a normal group. Other limitation was that the data were 
not analyzed according to the history of nulli and mul-
tiparity pregnancy, gestational diabetes mellitus (GDM), 
macrosomia and polycystic ovary syndrome (PCOS).
Conclusions
In conclusion, chronic hyperglycemia results in 
oxidative stress. This situation might lead to less beta 
cells function. The current study showed that obesity 
was associated with increased oxidative stress and 
disrupted oxidant/antioxidant balance. In addition, low 
levels of the A/L ratio or high levels of the L/A ratio were 
associated with increased oxidative stress.
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